Similar articles

• Trial effect in newly diagnosed pediatric acute lymphoblastic leukemia.

  Kulkarni KP, Arya LS. Kulkarni KP, et al. Arch Pediatr Adolesc Med. 2010 Sep;164(9):882; author reply 882-3. doi: 10.1001/archpediatrics.2010.141. Arch Pediatr Adolesc Med. 2010. PMID: 20819974 No abstract available.
• Clinical trials referral resource. Current clinical trials in pediatric acute lymphoblastic leukemia.

  Smith M, Newsome SY, Cheson BD. Smith M, et al. Oncology (Williston Park). 2000 Dec;14(12):1720, 1723-5. Oncology (Williston Park). 2000. PMID: 11204374 No abstract available.
• Progress in the curative treatment of childhood hematologic malignancies.

  Wayne AS, Reaman GH, Helman LJ. Wayne AS, et al. J Natl Cancer Inst. 2008 Sep 17;100(18):1271-3. doi: 10.1093/jnci/djn306. Epub 2008 Sep 9. J Natl Cancer Inst. 2008. PMID: 18780861 No abstract available.
• Biology and therapy of childhood acute lymphoblastic leukemia.

  Rivera GK, Crist WM, Sallan SE. Rivera GK, et al. Rev Invest Clin. 1994 Apr;Suppl:26-33. Rev Invest Clin. 1994. PMID: 7886304 Review. No abstract available.
• Facilitating care for childhood cancer survivors: integrating children's oncology group long-term follow-up guidelines and health links in clinical practice.

  Eshelman D, Landier W, Sweeney T, Hester AL, Forte K, Darling J, Hudson MM. Eshelman D, et al. J Pediatr Oncol Nurs. 2004 Sep-Oct;21(5):271-80. doi: 10.1177/1043454204268875. J Pediatr Oncol Nurs. 2004. PMID: 15381795 Review.